DFJ Growth, an investment company, led a $40m Series B round in Osmind, a platform for breakthrough mental health research and treatment, with participation from Susa Ventures, Lachy Groom, Brent Saunders, Helena Goodman, Ariel Katz, General Catalyst, Future Ventures, Tiger Global, and Pear VC. “Osmind supports clinicians treating patients with serious and refractory mental health conditions, including severe depression, suicidality, PTSD, substance use disorders, anxiety, OCD, and more. By enabling the serious innovation being led by interventional mental health practices, we are doing our part to help researchers expand better, safer, more effective treatments for patients who need it most,” Jimmy Qian, Osmind Co-Founder and COO.